Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: lwd who wrote (50068)	3/6/1999 2:01:00 PM
From: Knighty Tin	Respond to of 132070

Lisa, One of the great success stories in biotechnology and one of the great flops in stock price. I still love it as the fundamentals are terrific. They are growing revenues faster than Dell and reducing their net losses quickly. They have new funding to keep research strong. Caritcel sales were up 66 percent in 1998 and will grow at a similar rate this year. Epicel sales up 42%. I think they will soon have a major corporate partner for TGF-B2. So, if this were an internet company, it would be selling at $300 a share. I still see $30 in the future, but it is obviously a speculation. MB